I am a fan of Mgmt team and the outlook for EMR, however 2.5m options at 2.5c doesn’t really inspire future outlook confidence in me. Sure, it’s less than 0.12% dilution, and only worth ~$120k at current $.
Being that it is a “Employee Share Option” that is (or should be) designed to link company and share price performance to mgmt reward, surely at the start of 2020, we’d (hope to) be that far above 2.5c that options at 5c or 6c are still an excellent incentive. Otherwise, what are we striving for?
Am I reading into this too much?
Ann: Section 708A Notice and Appendix 3B, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.20 |
Change
-0.070(1.64%) |
Mkt cap ! $2.759B | |||
| Open | High | Low | Value | Volume |
| $4.25 | $4.27 | $4.19 | $6.304M | 1.496M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $4.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.20 | 4205 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| EMR (ASX) Chart |